Which Drug Cannot Pass the Blood-Brain Barrier?
•
3 min read
A remarkable 98% of small-molecule drugs and 100% of large-molecule biopharmaceuticals cannot effectively cross the blood-brain barrier (BBB), a sophisticated protective layer designed to keep harmful substances away from the brain. This creates a significant challenge for therapeutics, raising the critical question of which drug cannot pass the blood-brain barrier and why.
